These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 21464407)
1. Cervical amyloidoma successfully treated with bortezomib and dexamethasone. Farrell K; Stobo DB; Soutar R J Clin Oncol; 2011 Jun; 29(17):e512-3. PubMed ID: 21464407 [No Abstract] [Full Text] [Related]
2. First report of a medullar cord compression secondary to osseous plasmacytoma successfully treated with bortezomib and dexamethasone. Español I; Martínez A; López MD; Iturbe T; Tejedor A; García MC; Cavero S; Funes C; Ibáñez J Leuk Res; 2010 Apr; 34(4):e97-9. PubMed ID: 19836836 [TBL] [Abstract][Full Text] [Related]
3. The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens. Benevolo G; Larocca A; Gentile M; Pregno P; Gay F; Botto B; Frairia C; Evangelista A; Morabito F; Boccadoro M; Vitolo U; Palumbo A Cancer; 2011 May; 117(9):1884-90. PubMed ID: 21509765 [TBL] [Abstract][Full Text] [Related]
4. Amyloidosis. Benjamin M; Gibbs S BMJ; 2011 Nov; 343():d6326. PubMed ID: 22088395 [No Abstract] [Full Text] [Related]
5. Infiltration of the spinal cord in a patient with multiple myeloma. Varettoni M; Corso A; Zappasodi P; Calliada F; Castagnola C; Mangiacavalli S; Lazzarino M J Clin Oncol; 2008 Sep; 26(25):4207-9. PubMed ID: 18757337 [No Abstract] [Full Text] [Related]
6. [Combination of bortezomib and dexamethasone for newly diagnosed multiple myeloma]. Li J; Zeng LJ; Zhao Y; Su C; Huang BH Zhonghua Xue Ye Xue Za Zhi; 2009 Aug; 30(8):543-7. PubMed ID: 19954643 [TBL] [Abstract][Full Text] [Related]
7. [Effect of Velcade combined with Dexamethasone on multiple myeloma]. He Q; Zhao X; He Y; Tan D Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):864-7. PubMed ID: 20818081 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma. Gozzetti A; Defina M; Bocchia M; Fabbri A; Marchini E; Chitarrelli I; Lauria F Leuk Res; 2010 Nov; 34(11):e288-9. PubMed ID: 20557933 [No Abstract] [Full Text] [Related]
9. Multiple lipoma with hyperlipidemia in a multiple myeloma patient treated with bortezomib/dexamethazone. Gotoh M; Kitahara T; Sakuta J; Akahane D; Ohyashiki K Leuk Res; 2010 Apr; 34(4):e120-1. PubMed ID: 19875167 [No Abstract] [Full Text] [Related]
10. Quick response to bortezomib plus dexamethasone in a patient with AL amyloidosis in first relapse. Moscetti A; Saltarelli F; Bianchi MP; Monarca B; De Biase L; Porrini R; Antolino G; La Verde G Amyloid; 2011 Jun; 18 Suppl 1():152-4. PubMed ID: 21838469 [No Abstract] [Full Text] [Related]
11. [Efficacy of bortezomib combined dexamethasone in 24 patients with multiple myeloma]. Li J; Zhao Y; Luo SK; Huang BH; Ding Y; Tong XZ; Wang HH; Zheng D; Su C; Peng AH Ai Zheng; 2008 Apr; 27(4):429-34. PubMed ID: 18423132 [TBL] [Abstract][Full Text] [Related]
12. Bortezomib in multiple myeloma: treatment and retreatment. A single center experience. Warzocha K; Kraj M; Pogłód R; Kwaśniak B Acta Pol Pharm; 2008; 65(6):753-6. PubMed ID: 19172860 [No Abstract] [Full Text] [Related]
13. Bortezomib in combination with dexamethasone for a young multiple myeloma with t(8; 14). Li JY; Wang LX; Shen WY; Lu SF; Chen LJ; Lu H Leuk Res; 2009 Apr; 33(4):584-6. PubMed ID: 18829108 [No Abstract] [Full Text] [Related]
15. Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: first reported case. Katodritou E; Kartsios C; Gastari V; Verrou E; Mihou D; Banti A; Lazaraki G; Lazaridou A; Kaloutsi V; Zervas K Leuk Res; 2008 Feb; 32(2):339-41. PubMed ID: 17560647 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib in treatment of extramedullary plasmacytoma of the pancreas. Wei JY; Tong HY; Zhu WF; Liu H; Zhang FJ; Yu WJ; Jin J Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):329-31. PubMed ID: 19502179 [TBL] [Abstract][Full Text] [Related]
17. Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome. Chim CS Cancer Chemother Pharmacol; 2008 Jun; 62(1):181-2. PubMed ID: 17846773 [No Abstract] [Full Text] [Related]
18. [PAD regimen for relapsed or refractory patients with multiple myeloma]. Zhang YQ; Liang R; Bai QX; Zhang T; Yang L; Wang YW; Wang WQ; Gu HT; Shu MM; Zhu HF; Bai YN; Chen XQ Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):260-3. PubMed ID: 19731828 [TBL] [Abstract][Full Text] [Related]
20. [Very good partial response and long time to progression by short-term bortezomib plus dexamethasone therapy for a patient with relapsed and refractory multiple myeloma-a case report]. Fukushima T; Iwao H; Nakajima A; Miki M; Sakai T; Sawaki T; Tanaka M; Masaki Y; Hirose Y; Umehara H Gan To Kagaku Ryoho; 2009 Aug; 36(8):1387-9. PubMed ID: 19692786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]